Latest AI and machine learning research in liver transplantation for healthcare professionals.
Background and aims. The first direct-acting antivirals (DAAs) to treat the viral hepatitis C (HCV) became available in 2011. Despite numerous clinical studies of patient outcomes after treatment, few have evaluated changes in the liver microenvironment. Despite achieving sustained virologic response (SVR), patients may still experience adverse outcomes like cirrhosis and hepatocellular carcinoma....
Large language models (LLMs) have emerged as transformative technologies, revolutionizing natural language understanding and generation across various domains, including medicine. In this study, we investigated the capabilities, limitations, and generalizability of Generative Pre-trained Transformer (GPT) models in analyzing unstructured patient notes from large healthcare datasets to identify imm...
Annotation of liver biopsies, for disease staging is increasingly aided by digital pathology, however existing systems do not quantify inflammation an...
Despite long-standing success of hematopoietic stem cell transplantation (HSCT) in the treatment of blood cancers and severe immune disorders, monitor...
Hepatitis, a disease characterized by inflammation of the liver, is a leading global health challenge that contributes to over 1.3 million deaths annu...
The critical need for precise risk stratification in severe liver cirrhosis is underscored by its substantial 30-day mortality rates, demanding reliab...
Chronic kidney disease (CKD) affects millions worldwide and often progresses to end-stage renal disease (ESRD), for which kidney transplantation remai...
Cardiac allograft rejection (CAR) remains the leading cause of early graft failure after heart transplantation (HT). Current diagnostics, including hi...
Lung transplantation remains the only definitive treatment for patients with end-stage respiratory failure; however, it is burdened by a substantial r...
Sepsis-induced immunosuppression, characterized by lymphopenia, is associated with adverse outcomes. We aimed to identify distinct lymphocyte recovery...
Optimizing immunosuppressive therapy remains central to improving long-term outcomes after kidney transplantation. Both induction and maintenance ther...
INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health challenge, characterized by significant vari...
BACKGROUND: At present, there are no specialized models for predicting mortality risk in patients with alcoholic cirrhosis complicated by severe acute...
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a heterogeneous disease caused by multiple etiologies. It is characterized by exce...
BACKGROUND: Necroptosis, a recently identified mechanism of programmed cell death, exerts significant influence on various aspects of cancer biology, ...
Dysregulated mitophagy is essential for mitochondrial quality control within human cancers. However, identifying hub genes regulating mitophagy and de...
Non-alcoholic fatty liver disease (NAFLD) is one of the most widespread liver disorders on a global scale, posing a significant threat of progressin...
This letter comments on the article that developed and tested a machine learning model that predicts lymphovascular invasion/perineural invasion statu...
We sought to develop and validate a machine learning (ML) model for predicting multidimensional frailty based on clinical and laboratory data. Moreove...
The gut microbiota plays a vital role in human health, and significant effort has been made to predict human phenotypes, especially diseases, with the...